Managing and Treating VKC

Managing vernal keratoconjunctivitis (VKC) is a marathon, not a sprint. Because the condition is chronic and can last until puberty, the goal of treatment is to control inflammation with the least amount of long-term risk to your child’s vision ^[1][2]. The standard of care follows a “stepwise” approach, where treatments are added or adjusted based on the severity of the symptoms ^[3][4].

The Treatment Decision Tree

Step 1: Mild or Seasonal Symptoms

For children with mild itching and redness, treatment focuses on comfort and prevention:

• Conservative Measures: Avoidance of triggers like dust and wind, using cool compresses or preservative-free artificial tears to wash away allergens, and actively preventing eye rubbing by using protective goggles or cold gel masks ^[3][2].
• Maintenance Drops: Antihistamines and mast cell stabilizers (like olopatadine) are used daily to block the immediate allergic response ^[5][2].

Step 2: Moderate to Severe Symptoms

If the “cobblestone” bumps (giant papillae) are present or if the child has significant light sensitivity, maintenance therapy must be stronger:

• Immunomodulators (Steroid-Sparing Therapy): These are the “gold standard” for long-term VKC management. Cyclosporine A (e.g., Verkazia) and tacrolimus work by calming the Th2 cells that drive chronic inflammation ^[6][2].
  • Note: These medications are not “quick fixes.” It can take up to 3 months for cyclosporine to reach its full effect ^[3].
  • Tacrolimus is often considered more potent and may be used if cyclosporine is not enough ^[7][2].

Step 3: Acute Flare-Ups (The “Rescue” Step)

When symptoms become unbearable or the cornea is at risk, doctors use “rescue” medications:

• Topical Corticosteroids (Steroids): These are powerful and work quickly to stop inflammation. However, they should only be used in short, monitored cycles (e.g., 1–2 weeks) ^[2][8].
• Warning: Using steroids long-term without close monitoring is a sign of substandard care. It can lead to permanent vision loss from glaucoma or cataracts ^[9][10].

The “Bridge” Strategy

A common fear for parents is how to manage the child’s pain when steroids must be stopped after 2 weeks, but cyclosporine takes up to 3 months to work. Doctors do not simply leave a child in pain. They typically use a “bridge” strategy: slowly tapering the dose of the steroid while the immunomodulator builds up in the child’s system, while heavily supplementing with mast-cell stabilizers and cold compresses to manage the daily symptoms ^[2][11].

Advanced and Emerging Options

For children whose VKC does not respond to standard drops (refractory cases), specialists may consider:

• Supratarsal Injections: A shot of steroid medication delivered under the eyelid to provide long-lasting relief for severe inflammation ^[12].
• Biologics: Medications like omalizumab (Xolair) or dupilumab (Dupixent) are being studied for severe VKC. These are systemic (whole-body) treatments that target the specific immune pathways (like IgE or IL-4) causing the disease ^[13][14].

Identifying Quality Care

A high-quality treatment plan for VKC should include:

1. A Severity Score: Your doctor should use a tool like the Bonini score to track progress objectively ^[2].
2. Pressure Checks: If your child is on any steroid drop, their intraocular pressure (IOP) must be checked at every visit ^[2][10].
3. A Long-Term Plan: The plan should prioritize moving your child away from steroids and onto “steroid-sparing” maintenance like cyclosporine ^[15][16].

Practical Tips for Administering Eye Drops

Administering drops to a young, light-sensitive child who clamps their eyes shut is incredibly difficult. Here are practical tips:

• Have the child lie flat on their back.
• Instead of prying the eye open, place the drop in the inner corner (near the nose) of the closed eye. When they naturally blink or open the eye, the drop will roll in.
• Keep the artificial tears in the refrigerator (never freeze them), as the cold sensation can help numb the eye and reduce the immediate sting of the medicated drops. For more daily tips, see Long-Term Monitoring and Daily Care.